Also known as: R77,975; Pirodavir
Pirodavir is an antiviral compound that belongs to the class of capsid-binding antiviral agents. It acts by binding to the hydrophobic pocket of rhinovirus VP1 capsid protein, preventing viral attachment and uncoating. It was investigated as a nasal spray for prevention and treatment of common cold caused by rhinoviruses. Mediocon Inc manufactures Pirodavir API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 124610-07-9 |
| Molecular Formula | C19H25N6O4 |
| Molecular Weight | 417.44 g/mol |
| Grade | IP / BP / USP |
| Category | Antiviral Agent (Rhinovirus Inhibitor) |
| Appearance | White to off-white, crystalline powder |
| Solubility | Freely soluble in water, sparingly soluble in ethanol, practically insoluble in ether |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PIR/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pirodavir — CAS 124610-07-9 (CAS 124610-07-9) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pirodavir — CAS 124610-07-9 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance